Loading provider…
Loading provider…
Hematology & Oncology Physician in Jacksonville, FL
NPI: 1245229772Primary Practice Location
MAYO CLINIC
4500 San Pablo Rd S, Jacksonville, FL
Primary Employer
Mayo Clinic Jacksonville
mayoclinic.org
HQ Phone
Get MD Winston's Phone Numberphone_androidMobile
Get MD Winston's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2000 - 2026
TX State Medical License
1994 - 2026
MI State Medical License
1994 - 2013

American Board of Internal Medicine
Medical Oncology
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Fellowship • Hematology and Medical Oncology
1997 - 2000
Maimonides Medical Center
Residency • Internal Medicine
1991 - 1994
University of Santo Tomas
Medical School
Until 1986
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 96413Infusion of chemotherapy into a vein up to 1 hour | 294 | 405 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 217 | 354 |
| 3 | 96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 208 | 618 |
| 4 | 36591Collection of blood specimen from a completely implantable venous access device | 152 | 202 |
| 5 | J2405Injection, ondansetron hydrochloride, per 1 mg | 141 | 1,672 |
Authors: Babar Bashir, Amita Patnaik, Ira Winer, Randy Sweis, Marc Chamberlain, Brian Rini
Journal: Invest New Drugs
Publication Date: 2024-02-19
Lead Sponsor: Aulos Bioscience, Inc.
Intervention / Treatment: DRUG: Aldesleukin, DRUG: Nivolumab, DRUG: Avelumab, DRUG: AU-007
Lead Sponsor: Mayo Clinic
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Exemestane, DRUG: Letrozole, DRUG: Anastrozole, DRUG: Tamoxifen Citrate, DRUG: Systemic Chemotherapy